LFG
SLDB icon

Larson Financial Group’s Solid Biosciences SLDB Stock Holding History

Larson Financial Group’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.43K Buy
644
+14
+2% +$106 ﹤0.01% 2653
2026
Q1 		$4.54K Buy
630
+408
+184% +$2.62K ﹤0.01% 2651
2025
Q4 		$1.25K Buy
+222
New +$1.2K ﹤0.01% 2897

Other funds holding SLDB

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Larson Financial Group's SLDB Position: Q2 2026 in Review

Larson Financial Group increased its Solid Biosciences (SLDB) stake by 2.2% in Q2 2026, buying an estimated $106 and bringing the position to 644 shares worth $6.43K. The position accounts for ﹤0.01% of the portfolio, ranked #2653.

Larson Financial Group first reported a position in SLDB in Q4 2025 and has held it in 3 quarters since. 157 funds tracked by Wall St. Rank hold SLDB as of Q2 2026.

  • Larson Financial Group held 644 shares of Solid Biosciences worth $6.43K as of Q2 2026.
  • Larson Financial Group bought 14 Solid Biosciences shares in Q2 2026, an estimated $106.
  • Solid Biosciences made up ﹤0.01% of Larson Financial Group's portfolio in Q2 2026, its #2653 holding.
  • Larson Financial Group first reported a position in Solid Biosciences in Q4 2025 and has held it in 3 quarters since.
  • 157 funds tracked by Wall St. Rank held Solid Biosciences as of Q2 2026.

Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.